术中发生心脏骤停后的目标温度管理:一项多中心回顾性研究
这项多中心回顾性研究纳入2008至2013年间11个ICU收治的101例术中发生心脏骤停(IOCA)患者,描述目标温度管理(TTM,32–34°C)的实施方式、不良事件及与1年功能结局的关联。30例(29.7%)接受了TTM,TTM组感染风险增加(P=0.005),但心律失常、出血或代谢/电解质紊乱风险未增加。多因素分析显示,ROSC前至少一次除颤与1年良好功能结局正相关(OR 3.06,95%CI 1.05–8.95,P=0.04),急诊手术与1年良好功能结局负相关(OR 0.36,95%CI 0.14–0.95,P=0.038)。TTM使用与1年良好功能结局无独立关联(OR 0.82,95%CI 0.27–2.46,P=0.72)。
要点
- 术中发生心脏骤停后仅29.7%(30/101)的患者接受了TTM(32–34°C)。
- TTM组感染风险增加(P=0.005),但心律失常、出血、代谢/电解质紊乱风险未见增加。
- ROSC前至少一次除颤与1年良好功能结局正相关(OR 3.06,95%CI 1.05–8.95,P=0.04)。
- 急诊手术与1年良好功能结局负相关(OR 0.36,95%CI 0.14–0.95,P=0.038)。
- TTM使用与1年良好功能结局无独立关联(OR 0.82,95%CI 0.27–2.46,P=0.72)。
适用人群与场景
- 2008–2013年间入住11个ICU的术中发生心脏骤停(IOCA)后患者,共101例(女35例、男66例;中位年龄62岁,IQR 42–72)。
- 68例(67.3%)为ASA PS I至III级,57例(56.4%)接受急诊手术。
处置流程与药物剂量
- TTM定义为32–34°C的目标温度管理,30例(29.7%)患者接受了TTM。
研究设计与关键结果
- 研究类型为多中心回顾性研究,纳入11个ICU的101例IOCA后患者,主要结局为1年功能结局。
- 首次记录心律:无脉性电活动36例(35.6%)、心室颤动/心动过速20例(19.8%)、心搏停止44例(43.6%)。
- 从 collapse 到开始心肺复苏的中位时间为0 min(0–0),到ROSC的中位时间为10 min(4–20)。
- 接受TTM的30例(29.7%)患者感染风险增加(P=0.005),但心律失常、出血或代谢/电解质紊乱风险未增加。
- 多因素分析:ROSC前至少一次除颤与1年良好功能结局正相关(OR 3.06,95%CI 1.05–8.95,P=0.04)。
- 多因素分析:急诊手术与1年良好功能结局负相关(OR 0.36,95%CI 0.14–0.95,P=0.038)。
- TTM使用与1年良好功能结局无独立关联(OR 0.82,95%CI 0.27–2.46,P=0.72)。
证据类型、等级与局限
- 证据类型:多中心回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 本研究显示术中发生心脏骤停后TTM使用率不足三分之一,且TTM与感染风险增加相关(P=0.005),与出血或冠脉事件无关联。
- 本研究显示TTM未独立预测IOCA后1年良好功能结局(OR 0.82,95%CI 0.27–2.46,P=0.72)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Few outcome data are available about temperature management after intraoperative cardiac arrest (IOCA). We describe targeted temperature management (TTM) (32-34 °C) modalities, adverse events, and association with 1-year functional outcome in patients with IOCA.
METHODS: Patients admitted to 11 ICUs after IOCA in 2008-2013 were studied retrospectively. The main outcome measure was 1-year functional outcome.
RESULTS: Of the 101 patients [35 women and 66 men; median age, 62 years (interquartile range, 42-72)], 68 (67.3%) were ASA PS I to III and 57 (56.4%) had emergent surgery. First recorded rhythms were asystole in 44 (43.6%) patients, pulseless electrical activity in 36 (35.6%), and ventricular fibrillation/tachycardia in 20 (19.8%). Median times from collapse to cardiopulmonary resuscitation and return of spontaneous circulation (ROSC) were 0 min (0-0) and 10 min (4-20), respectively. The 30 (29.7%) patients who received TTM had an increased risk of infection (P = 0.005) but not of arrhythmia, bleeding, or metabolic/electrolyte disorders. By multivariate analysis, one or more defibrillation before ROSC was positively associated with a favorable functional outcome at 1-year (OR 3.06, 95% CI 1.05-8.95, P = 0.04) and emergency surgery was negatively associated with 1-year favorable functional outcome (OR 0.36; 95% CI 0.14-0.95, P = 0.038). TTM use was not independently associated with 1-year favorable outcome (OR 0.82; 95% CI 0.27-2.46, P = 0.72).
CONCLUSIONS: TTM was used in less than one-third of patients after IOCA. TTM was associated with infection but not with bleeding or coronary events in this setting. TTM did not independently predict 1-year favorable functional outcome after IOCA in this study.
参考来源
- Constant AL, Mongardon N, Morelot Q, et al. Targeted temperature management after intraoperative cardiac arrest: a multicenter retrospective study. Intensive Care Med. 2017. PMID: 28220232. doi:10.1007/s00134-017-4709-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。